Cargando…
Low Branched Chain Amino Acids and Tyrosine in Thai Patients with Type 2 Diabetes Mellitus Treated with Metformin and Metformin-Sulfonylurea Combination Therapies
Type 2 diabetes mellitus (T2DM) is a growing public health challenge for Thailand (current prevalence ~10.0%). Amino acids offer novel biomarkers to predict risk of T2DM and indicate sub-optimal disease management, which could facilitate earlier treatment. We studied amino acid profiles in a Thai co...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621185/ https://www.ncbi.nlm.nih.gov/pubmed/34830706 http://dx.doi.org/10.3390/jcm10225424 |
_version_ | 1784605396541898752 |
---|---|
author | Sriboonvorakul, Natthida Pan-Ngum, Wirichada Poovorawan, Kittiyod Muangnoicharoen, Sant Quinn, Lauren M. Tan, Bee K. |
author_facet | Sriboonvorakul, Natthida Pan-Ngum, Wirichada Poovorawan, Kittiyod Muangnoicharoen, Sant Quinn, Lauren M. Tan, Bee K. |
author_sort | Sriboonvorakul, Natthida |
collection | PubMed |
description | Type 2 diabetes mellitus (T2DM) is a growing public health challenge for Thailand (current prevalence ~10.0%). Amino acids offer novel biomarkers to predict risk of T2DM and indicate sub-optimal disease management, which could facilitate earlier treatment. We studied amino acid profiles in a Thai cohort comprising of individuals with T2DM (n = 65 single-drug-treated; n = 38 multi-drug-treated) compared to healthy controls (n = 104) using liquid chromatography-mass spectrometry. Age and BMI were significantly lower in the healthy controls compared to the single or multi-treated T2DM groups. The BCAA (leucine and valine) were significantly lower in the single and multi-treated T2DM groups compared to healthy controls (p < 0.001 and p < 0.001) and isoleucine was significantly lower in the single-treated compared to the healthy controls (p = 0.014). These findings beg the question whether BCAAs supplementation be beneficial in T2DM patients treated with single or multi-drug therapy? Tyrosine was significantly lower in the single and multi-treated T2DM groups compared to healthy controls (p < 0.001 and p = 0.002), whereas phenylalanine was significantly higher in the multi-treated T2DM group compared to the single treated T2DM group (p = 0.045). We provide novel insights into the effects of diabetes treatments on these amino acids in insulin resistant states such as T2DM in a unique but understudied Thai population. |
format | Online Article Text |
id | pubmed-8621185 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86211852021-11-27 Low Branched Chain Amino Acids and Tyrosine in Thai Patients with Type 2 Diabetes Mellitus Treated with Metformin and Metformin-Sulfonylurea Combination Therapies Sriboonvorakul, Natthida Pan-Ngum, Wirichada Poovorawan, Kittiyod Muangnoicharoen, Sant Quinn, Lauren M. Tan, Bee K. J Clin Med Article Type 2 diabetes mellitus (T2DM) is a growing public health challenge for Thailand (current prevalence ~10.0%). Amino acids offer novel biomarkers to predict risk of T2DM and indicate sub-optimal disease management, which could facilitate earlier treatment. We studied amino acid profiles in a Thai cohort comprising of individuals with T2DM (n = 65 single-drug-treated; n = 38 multi-drug-treated) compared to healthy controls (n = 104) using liquid chromatography-mass spectrometry. Age and BMI were significantly lower in the healthy controls compared to the single or multi-treated T2DM groups. The BCAA (leucine and valine) were significantly lower in the single and multi-treated T2DM groups compared to healthy controls (p < 0.001 and p < 0.001) and isoleucine was significantly lower in the single-treated compared to the healthy controls (p = 0.014). These findings beg the question whether BCAAs supplementation be beneficial in T2DM patients treated with single or multi-drug therapy? Tyrosine was significantly lower in the single and multi-treated T2DM groups compared to healthy controls (p < 0.001 and p = 0.002), whereas phenylalanine was significantly higher in the multi-treated T2DM group compared to the single treated T2DM group (p = 0.045). We provide novel insights into the effects of diabetes treatments on these amino acids in insulin resistant states such as T2DM in a unique but understudied Thai population. MDPI 2021-11-20 /pmc/articles/PMC8621185/ /pubmed/34830706 http://dx.doi.org/10.3390/jcm10225424 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Sriboonvorakul, Natthida Pan-Ngum, Wirichada Poovorawan, Kittiyod Muangnoicharoen, Sant Quinn, Lauren M. Tan, Bee K. Low Branched Chain Amino Acids and Tyrosine in Thai Patients with Type 2 Diabetes Mellitus Treated with Metformin and Metformin-Sulfonylurea Combination Therapies |
title | Low Branched Chain Amino Acids and Tyrosine in Thai Patients with Type 2 Diabetes Mellitus Treated with Metformin and Metformin-Sulfonylurea Combination Therapies |
title_full | Low Branched Chain Amino Acids and Tyrosine in Thai Patients with Type 2 Diabetes Mellitus Treated with Metformin and Metformin-Sulfonylurea Combination Therapies |
title_fullStr | Low Branched Chain Amino Acids and Tyrosine in Thai Patients with Type 2 Diabetes Mellitus Treated with Metformin and Metformin-Sulfonylurea Combination Therapies |
title_full_unstemmed | Low Branched Chain Amino Acids and Tyrosine in Thai Patients with Type 2 Diabetes Mellitus Treated with Metformin and Metformin-Sulfonylurea Combination Therapies |
title_short | Low Branched Chain Amino Acids and Tyrosine in Thai Patients with Type 2 Diabetes Mellitus Treated with Metformin and Metformin-Sulfonylurea Combination Therapies |
title_sort | low branched chain amino acids and tyrosine in thai patients with type 2 diabetes mellitus treated with metformin and metformin-sulfonylurea combination therapies |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621185/ https://www.ncbi.nlm.nih.gov/pubmed/34830706 http://dx.doi.org/10.3390/jcm10225424 |
work_keys_str_mv | AT sriboonvorakulnatthida lowbranchedchainaminoacidsandtyrosineinthaipatientswithtype2diabetesmellitustreatedwithmetforminandmetforminsulfonylureacombinationtherapies AT panngumwirichada lowbranchedchainaminoacidsandtyrosineinthaipatientswithtype2diabetesmellitustreatedwithmetforminandmetforminsulfonylureacombinationtherapies AT poovorawankittiyod lowbranchedchainaminoacidsandtyrosineinthaipatientswithtype2diabetesmellitustreatedwithmetforminandmetforminsulfonylureacombinationtherapies AT muangnoicharoensant lowbranchedchainaminoacidsandtyrosineinthaipatientswithtype2diabetesmellitustreatedwithmetforminandmetforminsulfonylureacombinationtherapies AT quinnlaurenm lowbranchedchainaminoacidsandtyrosineinthaipatientswithtype2diabetesmellitustreatedwithmetforminandmetforminsulfonylureacombinationtherapies AT tanbeek lowbranchedchainaminoacidsandtyrosineinthaipatientswithtype2diabetesmellitustreatedwithmetforminandmetforminsulfonylureacombinationtherapies |